View in EDS

GFAP and NfL as predictors of disease progression and relapse activity in fingolimod-treated multiple sclerosis.

Saved in:
Bibliographic Details
Title: GFAP and NfL as predictors of disease progression and relapse activity in fingolimod-treated multiple sclerosis.
Authors: Maceski, Aleksandra Maleska1, Benkert, Pascal2, Einsiedler, Maximilian1, Schaedelin, Sabine2, Oechtering, Johanna1, Melie-Garcia, Lester3, Cagol, Alessandro4, Galbusera, Riccardo3, Galli, Edoardo1, Müller, Jannis3
Source: Brain: A Journal of Neurology; Jul2026, Vol. 149 Issue 7, p2295-2307, 13p
Database: Applied Science & Technology Source
Be the first to leave a comment!
You must be logged in first